All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

18

Reset

18 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • luvometinibFCN-159Phase 34 trials

    Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Non-small Cell Lung Caner, KRAS-mutated, Metastasis

  • SafusidenibDS-1001b, AB-218Phase 34 trials

    Nuvation Bio Inc. · Oligodendroglioma, Glioma, IDH1-mutant Glioma

  • APG-157Phase 33 trials

    Aveta Biomics, Inc. · Head and Neck Cancer, Squamous Cell Carcinoma of Oral Cavity, Squamous Cell Carcinoma of the Oropharynx

  • VRT106Phase 33 trials

    Guangzhou Virotech Pharmaceutical Co., Ltd. · Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, HCC

  • CobolimabPhase 32 trials

    GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma

  • LAM561Phase 32 trials

    Laminar Pharmaceuticals · Primary Glioblastoma, Glioblastoma Multiforme, High-grade Glioma

  • Fianlimab [Fixed ]Phase 22 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • silevertinibBDTX-1535Phase 22 trials

    Black Diamond Therapeutics, Inc. · Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM

  • BCB-276Phase 21 trial

    BrainChild Bio, Inc · Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor

  • BioTTT001Phase 21 trial

    Beijing Bio-Targeting Therapeutics Technology Co., Ltd · Recurrent High-grade Glioma

  • FG001Optical imaging agent FG001, Fluorescent imaging agent FG001Phase 21 trial

    FluoGuide A/S · High-Grade Glioma (WHO III-IV)

  • HX301Phase 21 trial

    Hangzhou Hanx Biopharmaceuticals, Ltd. · Glioma

  • JBI-778Phase 21 trial

    Jubilant Therapeutics Inc. · Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG)

  • LSAM-CisplatinPhase 21 trial

    NanOlogy, LLC (doing business as Intryx Therapeutics, LLC) · Diffuse Midline Glioma (DMG), Diffuse Intrinsic Pontine Glioma (DIPG), Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma

  • TGX-007Phase 21 trial

    Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma

  • TNG456Phase 21 trial

    Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant

  • VAL-083Phase 21 trial

    Kintara Therapeutics, Inc. · Glioma, Glioblastoma, Glioblastoma Multiforme

  • ValaciclovirPhase 21 trial

    Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.